3 Ways Medicare Drug Price Negotiations Will Impact Pharma
The IRA is a sea change for drug pricing. Negotiating prices with CMS, which can leverage the full force of the Medicare population, will create a new dynamic for pharmaceutical companies. And the shift in controlling out-of-pocket costs may force manufacturers to tighten cost structures.
